Radiation therapy is the mainstay therapeutic modality for nasopharyngeal carcinoma (NPC). In the last two decades, advances in the diagnostic and treatment techniques in cancer management have significantly improved prognosis of NPC, including the long-term local and regional disease control as well as patients' overall survival. With definitive radiation therapy for early stage disease and combined chemoradiother-apy for locoregionally advanced disease, the overall survival of NPC patients exceed 80% at 5 years (Wee et al. 2005; Cheng et al. 2000).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anne PR, Machtay M, Rosenthal DI, et al (2007) A phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 67(2):445–452
Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D (1996) Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56(11):2484–2487
Boschetti M, De Lucchi M, Giusti M, et al (2006) Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease. Eur J Endocrinol 154(6):813–818
Bowen BC, Verma A, Brandon AH, Fiedler JA (1996) Radiation-induced brachial plexopathy: MR and clinical findings. AJNR Am J Neuroradiol 17(10):1932–1936
Buntzel J, Kuttner K, Frohlich D, Glatzel M (1998) Selective cytoprotection with amifostine in concurrent radiochemo-therapy for head and neck cancer. Ann Oncol 9(5):505–509
Calabro F, Jinkins JR (2000) MRI of radiation myelitis: a report of a case treated with hyperbaric oxygen. Eur Radiol 10(7):1079–1084
Chan SH, Ng WT, Kam KL, et al (2009) Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 73(5):1335–1342
Cheng SH, Jian JJ, Tsai SY, et al (2000) Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 48(5):1323–1330
Chen WC, Jackson A, Budnick AS, et al (2006) Sensorineural hearing loss in combined modality treatment of nasopha-ryngeal carcinoma. Cancer 106(4):820–829
Cheung MC, Chan AS, Law SC, Chan JH, Tse VK (2003) Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer 97(8):2019–2026
Cheung M, Chan AS, Law SC, Chan JH, Tse VK (2000) Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol 57(9):1347–1352
Chowdhury CR, Ho JH, Wright A, Tsao SY, Au GK, Tung Y (1988). Prospective study of the effects of ventilation tubes on hearing after radiotherapy for carcinoma of nasopharynx. Ann Otol Rhinol Laryngol 97(2 Pt 1):142–145
Chua DT, Lo C, Yuen J, Foo YC (2001) A pilot study of pentoxi-fylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24(4):366–369
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346
Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M (1994) Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 32(1):12–20
Delanian S, Balla-Mekias S, Lefaix JL (1999) Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17 (10):3283–3290
Dikshit R P, Boffetta P, Bouchardy C, et al (2005) Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 103(11):2326–2333
Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA (2001) Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50(3):695–704
Eisbruch A, Ship JA, Dawson LA, et al (2003) Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27(7):832–837
Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45(3):577–587
Emami B, Lyman J, Brown A, et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122
Epstein JB, Emerton S, Kolbinson DA, et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21(1):1–11
Fajardo L-G LF, Berthrong M, Anderson RE (eds) (2001) Endocrine glands: hypothalamic-hypophyseal axis. In: Radiation pathology. Oxford University Press, New York, pp 331–336
Fathers E, Thrush D, Huson SM, Norman A (2002) Radiation-induced brachial plexopathy in women treated for carcinoma of the breast. Clin Rehabil 16(2):160–165
Fisher J, Scott C, Scarantino CW, et al (2003) Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer — RTOG 97-09. Int J Radiat Oncol Biol Phys 56(3):832–836
Formanek M, Czerny C, Gstoettner W, Kornfehl J (1998) Cochlear implantation as a successful rehabilitation for radiation-induced deafness. Eur Arch Otorhinolaryngol 255(4):175–178
Gamble JE, Peterson EA, Chandler JR (1968) Radiation effects on the inner ear. Arch. Otolaryngol. 88:64–69
Gao X, Fisher SG, Mohideen N, Emami B (2003) Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 56(2):427–435
Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z (1995) Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 31(5):1309–1318
Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44(11):2020–2027
Hamlar DD, Schuller DE, Gahbauer RA, et al (1996) Determina tion of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 106(8):972–976
Harper CM Jr, Thomas JE, Cascino TL, Litchy WJ (1989) Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology 39(4):502–506
Harrison LB, Zelefsky MJ, Pfister DG, et al (1997) Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 19(3):169–175
Henson BS, Inglehart MR, Eisbruch A, Ship JA (2001) Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 37(1):84–93
Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2009) Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 73(3):779–788
Hoeller U, Bonacker M, Bajrovic A, Alberti W, Adam G (2004) Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool? Strahlenther Onkol 180(10):650–654
Homann N, Nees M, Conradt C, et al (2001) Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 7(2):290–296
Huang S, Chu G (1981) Nasopharyngeal cancer: study II. Int J Radiat Oncol Biol Phys 7(6):713–716
Jacobs CD, van der Pas M (1996) A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncology (Williston Park) 10(3 Suppl):16–20
Janzen AH, Warren S (1942) Effect of roentgen rays on the peripheral nerve of the rat. Radiology 38:333–337
Jellema AP, Langendijk H, Bergenhenegouwen L, et al (2001) The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilotstudy. Radiother Oncol 59(2):157–160
Jen YM, Hsu WL, Chen CY, et al (2001) Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques. Int J Radiat Oncol Biol Phys 51(2):344–348
Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R (2003) Radiotherapy-induced ear toxicity. Cancer Treat Rev 29(5):417–430
Johansson S, Svensson H, Denekamp J (2000) Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48(3):745–750
Johansson S, Svensson H, Denekamp J (2002) Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 52(5):1207–1219
Johnson JT, Ferretti GA, Nethery WJ, et al (1993) Oral pilo-carpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329(6):390–395
Kam MK, Teo PM, Chau RM, et al (2004) Treatment of nasopha-ryngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440–1450
Kies MS, Haraf DJ, Rosen F, et al (2001) Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyper-fractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19(7):1961–1969
Killer HE, Hess K (1990) Natural history of radiation-induced brachial plexopathy compared with surgically treated patients. J Neurol 237(4):247–250
Kluver H, Bucy PC (1997) Preliminary analysis of functions of the temporal lobes in monkeys. J Neuropsychiatry Clin Neurosci Fall;9(4):606–620
Kong L, Lu JJ (2009) Second primary tumor. In: Schwab M (ed) Encyclopedia of cancer. Springer, Berlin
Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y (2006) The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer 107(6):1287–1293
Koukourakis MI (2002) Amifostine in clinical oncology: current use and future applications. Anticancer Drugs 13(3):181–209
Koukourakis MI, Kyrias G, Kakolyris S, et al (2000) Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. J Clin Oncol 18(11):2226–2233
Lam KS, Ho JH, Lee AW, et al (1987) Symptomatic hypotha-lamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study. Int J Radiat Oncol Biol Phys 13(9):1343–1350
Lam KS, Tse VK, Wang C, Yeung RT, Ho JH (1991) Effects of cranial irradiation on hypothalamic-pituitary function — a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 78(286):165–176
Lam KS, Tse VK, Wang C, Yeung RT, Ma JT, Ho JH (1987) Early effects of cranial irradiation on hypothalamic-pituitary function. J Clin Endocrinol Metab 64(3):418–424
Lam KS, Wang C, Yeung RT, et al (1986) Hypothalamic hypopi-tuitarism following cranial irradiation for nasopharyngeal carcinoma. Clin Endocrinol (Oxf) 24(6):643–651
Lau SK, Wei WI, Sham J, Hui Y, Choy D (1992) Effect of irradiation on middle ear effusion due to nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 17(3):246–250
Lee A (1999) Complications of radiation therapy. In: Van Hasselt CA, Gibb AG (eds) Nasopharyngeal carcinoma. 2nd ed. The Chinese University of Hong Kong Press & Greenwich Medical Media, Hong Kong, pp 255–275
Lee AW, Foo W, Chappell R, et al (1998) Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40(1):35–42
Lee AW, Kwong DL, Leung SF, et al (2002) Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53(1):75–85
Lee AW, Lau WH, Tung SY, et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyn-geal carcinoma: NPC-9901 Trial by the Hong Kong Nasopha ryngeal Cancer Study Group. J Clin Oncol 23(28):6966–6975
Lee AW, Law SC, Ng SH, et al (1992) Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiation. Br J Radiol 65(778):918–928
Lee AWMPC, Law SCK, Chua DTT, Wei WI, Chong V (2008) Nasopharynx. In: Halperin EC, Perez C, Brady LW (eds) Perez and Brady's principles and practice of radiation oncology. 5th ed. Lippincott, Philadelphia, pp 820–857
Lee AW, Ng SH, Ho JH, et al (1988) Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer 61(8):1535–1542
Lee AW, Ng SH, Tse VK, Chiu HM, Thaw M (1993) Bilateral temporal lobectomy for necrosis induced by radiotherapy for nasopharyngeal carcinoma. Acta Oncol 32(3):343–344
Lee AW, Ng WT, Hung WM, et al (2009) Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys 73(4):1121–1128
Lee AW, Sze WM, Fowler JF, Chappell R, Leung SF, Teo P (1999) Caution on the use of altered fractionation for nasopha-ryngeal carcinoma. Radiother Oncol 52(3):207–211
Lee N, Harris J, Garden AS (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopha-ryngeal carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225. J Clin Oncol
Lee N, Xia P, Quivey JM, et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53(1):12–22
Lennox AJ, Shafer JP, Hatcher M, Beil J, Funder SJ (2002) Pilot study of impedance-controlled microcurrent therapy for managing radiation-induced fibrosis in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 54(1):23–34
Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21(3):204–210
LeQuang C (1989) Postirradiation lesions of the brachial plexus. Results of surgical treatment. Hand Clin 5(1):23–32
LeVeque FG, Montgomery M, Potter D, et al (1993) A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 11(6):1124–1131
Levine MJ, Aguirre A, Hatton MN, Tabak LA (1987) Artificial salivas: present and future. J Dent Res 66:Spec No 693–698
Levy RL, Miller NR (2006) Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore 35(3):151–157
Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity- modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys Apr 11. [Epub ahead of print]
Lin YS, Jen YM, Lin JC (2002) Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma. Cancer 95(2):404–409
Liu RP, Fleming TJ, Toth BB, Keene HJ (1990) Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol 70(6):724–729
Malouf JG, Aragon C, Henson BS, Eisbruch A, Ship JA (2003) Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev 27(4):305–310
Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA (1982) Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 50(6):1042–1050
Mendes DG, Nawalkar RR, Eldar S (1991) Post-irradiation femoral neuropathy. A case report. J Bone Joint Surg Am 73(1):137–140
Mesic JB, Fletcher GH, Goepfert H (1981) Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7(4):447–453
Mihalcea O, Arnold AC (2008) Side effect of head and neck radiotherapy: optic neuropathy. Oftalmologia 52(1):36–40
Murphy BA, Gilbert J (2009) Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol 19(1):35–42
Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A, et al (2003) Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Oral Oncol 39(4):397–401
O'Sullivan B, Levin W (2003) Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 13(3):274–289
Parsons J (1994)Time-dose-volume relations in radiation therapy. In: Million RR CN (ed) Management of head and neck cancer a multidisciplinary approach, 2nd edn. Lippincott, Philadelphia, PA, pp 204–244
Pierce SM, Recht A, Lingos TI, et al (1992) Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23(5):915–923
Powell S, Cooke J, Parsons C (1990) Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 18(3):213–220
Rieke JW, Hafermann MD, Johnson JT, et al (1995) Oral pilo-carpine for radiation-induced xerostomia: integrated effi-cacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 31(3):661–669
Ronchetti D, Arisi E, Neri A, et al (2005) Microsatellite analyses of recurrence or second primary tumor in head and neck cancer. Anticancer Res 25(4):2771–2775
Rubin DI, Schomberg PJ, Shepherd RF, Panneton JM (2001) Arteritis and brachial plexus neuropathy as delayed complications of radiation therapy. Mayo Clin Proc 76(8):849–852
Rudat V, Meyer J, Momm F, et al (2000) Protective effect of ami-fostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys 48(5):1339–1343
Salner AL, Botnick LE, Herzog AG, et al (1981) Reversible brachial plexopathy following primary radiation therapy for breast cancer. Cancer Treat Rep 65(9–10):797–802
Saunders WH, Hodgson SE (1979) Bilateral hypoglossal nerve paralysis after irradiation therapy. Ann Otol Rhinol Laryngol 88(4 Pt 1):515–517
Schultheiss TE, Kun LE, Ang KK, Stephens LC (1995). Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31(5):1093–1112
Sham J, Choy D, Kwong PW, et al (1994) Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Int J Radiat Oncol Biol Phys 29(4):699–704
Skinner DW, Lesser TH, Richards SH (1988) A 15 year follow-up of a controlled trial of the use of grommets in glue ear. Clin Otolaryngol Allied Sci 13(5):341–346
Slaughter D P, Southwick HW, Smejkal W (1953) Field cancer-ization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968
Sloan AE, Arnold SM, St Clair WH, Regine WF (2003) Brain injury: current management and investigations. Semin Radiat Oncol 13(3):309–321
Spielman AI (1990) Interaction of saliva and taste. J Dent Res 69(3):838–843
St Clair WH, Arnold SM, Sloan AE, et al (2003) Spinal cord and peripheral nerve injury: current management and investigations. Semin Radiat Oncol 13(3):322–332
Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH (1986) Unique radiosensitivity of serous cells in rhesus monkey submandibular glands. Am J Pathol 124(3):479–487
Stinson SF, DeLaney TF, Greenberg J, et al (1991) Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys 21(6):1493–1499
Stoll BA, Andrews JT (1966) Radiation-induced peripheral neuropathy. Br Med J 1:834–837
Stryker JA, Sommerville K, Perez R, Velkley DE (1990) Sacral plexus injury after radiotherapy for carcinoma of cervix. Cancer 66(7):1488–1492
Sultanem K, Shu HK, Xia P, et al (2000) Three-dimensional intensity-modulated radiotherapy in the treatment of nasopha-ryngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48(3):711–722
Trotti A, Colevas AD, Setser A, et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181
Vacha P, Fehlauer F, Mahlmann B, et al (2003) Randomized phase III trial of postoperative radiochemotherapy +/-amifostine in head and neck cancer. Is there evidence for radioprotection? Strahlenther Onkol 179(6):385–389
van Oijen MG, Leppers Vd Straat FG, Tilanus MG, Slootweg PJ (2000) The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 88(4):884–893
Wang X, Lu JJ, Xiong X, et al (2009) Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma? Med Dosim
Warde P, O'Sullivan B, Aslanidis J, et al (2002) A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 54(1):9–13
Wee J, Tan EH, Tai BC, et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23(27):6730–6738
Wescott WB, Mira JG, Starcke EN, Shannon IL, Thornby JI (1978) Alterations in whole saliva flow rate induced by fractionated radiotherapy. AJR Am J Roentgenol 130(1):145–149
Yamamoto E, Shibuya H, Yoshimura R (2002) Miura M. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 94(7):2007–2014
Ye h SA, Tang Y, Lui CC, Huang YJ, Huang EY (2005) Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62(3):672–679
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lo, S.S., Lu, J.J., Kong, L. (2010). Long-Term Complications in the Treatment of Nasopharyngeal Carcinoma. In: Lu, J.J., Cooper, J.S., Lee, A.W.M. (eds) Nasopharyngeal Cancer. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92810-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-540-92810-2_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-92809-6
Online ISBN: 978-3-540-92810-2
eBook Packages: MedicineMedicine (R0)